Cover Image

Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Gabriel Gárate, Julio Pascual
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Author Response to Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”
by: Ann I. Scher, et al.
Published: (2024)

Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study
by: Marta Pascual‐Mato, et al.
Published: (2024)

Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
by: Irina Krikova, et al.
Published: (2024)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
by: Andrea M. Kuczynski, et al.
Published: (2025)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
by: Kara S. Graves, et al.
Published: (2026)

Amplifying and ameliorating light avoidance in mice with photoreceptor targeting and calcitonin gene‐related peptide sensitization
by: Eric A. Kaiser, et al.
Published: (2025)

Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
by: Samuel K. Peasah, et al.
Published: (2024)

Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists
by: Zoe Tasma, et al.
Published: (2025)

Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors
by: Alex Harlan, et al.
Published: (2025)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
by: Anna de Dios, et al.
Published: (2024)

Arterial hypertension: A safety risk of calcitonin gene‐related peptide ligand and receptor blocker class
by: David Croteau, et al.
Published: (2026)

Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
by: Alba López‐Bravo, et al.
Published: (2025)

Treatment of abdominal migraine in an 8‐year‐old child with calcitonin gene‐related peptide receptor antagonist: A case report
by: Yunzhu Tang, et al.
Published: (2025)

Letter to the Editor regarding “Persistence, effectiveness, and tolerability of anti‐calcitonin gene‐related peptide monoclonal antibodies in patients with chronic migraine”
by: Joaquín Borrás‐Blasco, et al.
Published: (2025)

American Headache Society white paper on treatment of post‐traumatic headache from concussion in youth
by: Carlyn Patterson Gentile, et al.
Published: (2024)

The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure
by: Tzu‐Hsuan Su, et al.
Published: (2024)

Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials
by: Jennifer Robblee, et al.
Published: (2024)

Transcutaneous electrical nerve stimulation of the occipital nerves as treatment for chronic cluster headache
by: Ida Stisen Fogh‐Andersen, et al.
Published: (2024)

Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays
by: Michael L. Garelja, et al.
Published: (2025)

Response to: Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays
by: Alicia Alpuente, et al.
Published: (2026)

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache
by: Genaro G. Gutierrez, et al.
Published: (2025)

The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model
by: Janosch Fox, et al.
Published: (2024)

Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache
by: Roemer B. Brandt, et al.
Published: (2025)

Response to Letter to the Editor regarding “Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays”
by: Michael L. Garelja, et al.
Published: (2026)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
by: Alexander Yoo, et al.
Published: (2025)

Case report: Treatment of temporomandibular joint disorder pain with V3 nerve block procedure
by: Dean Zeldich, et al.
Published: (2025)

Beneficial effect of infiltration around the greater occipital nerve in cluster headache independent of modulation of the nociceptive blink reflex
by: Willemijn C. Naber, et al.
Published: (2025)

Comfort matters: A new strategy to ease injection pain during headache treatment procedures
by: Hannah F. J. Shapiro
Published: (2026)

Cluster headache vs. labor: A comparative perspective on acute pain during and after delivery
by: Joudi Sharaf, et al.
Published: (2025)

Youth with high‐frequency headaches due to migraine are more vulnerable to non‐cephalic pain complaints
by: Brooke L. Reidy, et al.
Published: (2025)

Temporary occipital nerve stimulation as transitional therapy for chronic intractable cluster headache: A case report and proof of concept
by: Keshet Pardo, et al.
Published: (2026)

Greater occipital nerve block for chronic headache management in children and adolescents: A longitudinal observational study and systematic review
by: Maria Morozova, et al.
Published: (2025)

The clinical effect of an implanted vagus nerve stimulator in a patient with chronic cluster headache and focal epilepsy – A case report
by: Paulien J. van Tilborg, et al.
Published: (2025)

Today in headache medicine: Helpful analogies in headache medicine
by: Medha Tandon, et al.
Published: (2025)

Is poor dietary quality in adolescence a risk factor for painful temporomandibular disorders and headaches in young adulthood? A prospective study in the Danish National Birth Cohort
by: Mojdeh Mansoori, et al.
Published: (2025)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
by: Christopher C. Anderson, et al.
Published: (2024)

Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study
by: Heiko Pohl, et al.
Published: (2024)

Identifying and predicting headache trajectories among those with acute post‐traumatic headache
by: Lingchao Mao, et al.
Published: (2025)

The impact of headache intensity on speech in participants with migraine and acute post‐traumatic headache
by: Dani C. Smith, et al.
Published: (2024)

Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample
by: Christina Murphy, et al.
Published: (2024)